FDA’s efforts to combat drug shortages include a flexible regulatory approach towards getting alternatives towards market and muscular public relations activity aimed at making the public aware of its efforts as it pushes for legislation to expand its powers.
The most recent example of that one-two punch at the problem was an unusual Feb
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?